Targeted toxin therapy for malignant astrocytoma

Neurosurgery

Volumn 46, Issue 3, 2000, Pages 544-552

  Hall, Walter A ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Box 96 Mayo ^*  (United States)

Author keywords

Brain neoplasm; Diphtheria toxin; Immunotoxin; Leptomeningeal tumor; Toxins; Transferrin receptor

Indexed keywords

ABRIN; ABRIN A; ALPHA SARCIN; BACTERIAL TOXIN; DIPHTHERIA TOXIN; DOXORUBICIN; GELONIN; IMMUNOGLOBULIN G; IMMUNOTOXIN; INTERLEUKIN 4 RECEPTOR; ION; MODECCIN; MOMORDICA CHARANTHIA INHIBITOR; MONOCLONAL ANTIBODY; MYCOTOXIN; PLANT TOXIN; POKEWEED ANTIVIRUS PROTEIN; PSEUDOMONAS EXOTOXIN; RICIN; RICIN A; SAPORIN; SZ 39; TOXIN; TRANSFERRIN RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ASTROCYTOMA; CANCER CELL CULTURE; CANCER REGRESSION; CANCER SURVIVAL; CYTOTOXICITY; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG MECHANISM; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; TREATMENT OUTCOME;

EID: 0034095489     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-200003000-00003     Document Type: Review

References (33)

1. Hall WA: Targeted toxin therapy, in Kornblith PL, Walker MD (eds): Advances in Neuro-Oncology II. Armonk, Futura Publishing Co., 1997, pp 505-516.
2. Hall WA, Fodstad Ø: Immunotoxins and central nervous system neoplasia. J Neurosurg 76:1-12, 1992.
3. Hall WA, Djalilian HR, Sperduto PW, Cho KH, Gerbi BJ, Gibbons J, Rohr M, Clark HB: Stereotactic radiosurgery for recurrent malignant gliomas. J Clin Oncol 13:1642-1648, 1995.
4. Hall WA, Godal A, Juell S, Fodstad Ø: In vitro efficacy of transferrin-toxin conjugates against glioblastoma multiforme. J Neurosurg 76:838-844, 1992.
5. Hall WA, Merrill MJ, Walbridge S, Youle RJ: Epidermal growth factor receptors on ependymomas and other brain tumors. J Neurosurg 72:641-646, 1990.
6. Hall WA, Myklebust A, Godal A, Nesland JM, Fodstad Ø: In vivo efficacy of transferrin-Pseudomonas exotoxin A immunotoxin against LOX melanoma. Neurosurgery 34:649-656, 1994.
7. Humphrey PA, Wong AJ, Vogelstein B, Friedman HS, Werner MH, Bigner DD, Bigner SH: Amplification and expression of the epidermal growth factor receptor gene in human glioma xenografts. Cancer Res 48:2231-2238, 1988.
8. Husain SR, Behari N, Kreitman RJ, Pastan I, Puri RK: Complete regression of established human glioblastoma tumor xenograft by interleukin-4 toxin therapy. Cancer Res 58:3649-3653, 1998.
9. Johnson VG, Wrobel C, Wilson D, Zovickian J, Greenfield L, Oldfield EH, Youle R: Improved tumor-specific immunotoxins in the treatment of CNS and leptomeningeal neoplasia. J Neurosurg 70:240-248, 1989.
10. Kreitman RJ, Pastan I: Accumulation of a recombinant immunotoxin in a tumor in vivo: Fewer than 1000 molecules are sufficient for complete responses. Cancer Res 58:968-975, 1998.
11. Kreitman RJ, Puri RK, Pastan I: Increased antitumor activity of a circularly permuted interleukin 4-toxin in mice with interleukin 4 receptor-bearing human carcinoma. Cancer Res 55:3357-3363, 1995.
12. Kunwar S, Pai LH, Pastan I: Cytotoxicity and antitumor effects of growth factor-toxin fusion proteins on human glioblastoma multiforme cells. J Neurosurg 79:560-576, 1993.
13. Laske DW, Ilercil O, Akbasak A, Youle RJ, Oldfield EH: Efficacy of direct intratumoral therapy with targeted protein toxins for solid human gliomas. J Neurosurg 80:520-526, 1994.
14. Laske DW, Muraszko KM, Oldfield EH, DeVroom HL, Sung C, Dedrick RL, Simon TR, Colandrea J, Copeland C, Katz D, Greenfield L, Groves ES, Houston LL, Youle RJ: Intraventricular immunotoxin therapy for leptomeningeal neoplasia. Neurosurgery 41:1039-1049, 1997.
15. Laske DW, Youle RJ, Oldfield EH: Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors. Nat Med 3:1362-1368, 1997.
16. Libermann TA, Nusbaum HR, Razon N, Kris R, Lax I, Spreq H, Whittle N, Waterfield MD, Ullrich A, Schlessinger J: Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumors of glial origin. Nature 313:144-147, 1985.
17. Martell LA, Agrawal A, Ross DA, Muraszko KM: Efficacy of transferrin-receptor targeted immunotoxins in brain tumor cell lines and pediatric brain tumors. Cancer Res 53:1348-1353, 1993.
18. Multani PS, Grossbard ML: Monoclonal antibody-based therapies for hematologic malignancies. J Clin Oncol 16:3691-3710, 1998.
19. Muraszko K, Sung C, Walbridge S, Greenfield L, Dedrick RL, Oldfield EH, Youle RJ: Pharmacokinetics and toxicology of immunotoxins administered into the subarachnoid space in nonhuman primates and rodents. Cancer Res 53:3752-3757, 1993.
20. Myklebust AT, Godal A, Fodstad Ø: Targeted therapy with immunotoxins in a nude rat model for leptomeningeal growth of human small cell lung cancer. Cancer Res 54:2146-2150, 1994.
21. Myklebust AT, Helseth A, Breistøl K, Hall WA, Fodstad Ø: Nude rat models for human tumor metastasis to the CNS: Procedures for intracarotid delivery of cancer cells and drugs. J Neurooncol 21:215-224, 1994.
22. Pastan IH, Archer GE, McLendon RE, Friedman HS, Fuchs HE, Wang QC, Pai LH, Herndon J, Bigner DD: Intrathecal administration of single-chain immunotoxin, LMB-7[B3(Fv)-PE38], produces cures of carcinomatous meningitis in a rat model. Proc Natl Acad Sci U S A 92:2765-2769, 1995.
23. Puri RK, Hoon DS, Leland P, Snoy P, Rand RJ, Pastan I, Kreitman RJ: Preclinical development of a recombinant toxin containing circularly permuted interleukin 4 and truncated Pseudomonas exotoxin for therapy of malignant astrocytoma. Cancer Res 56:5631-5637, 1996.
24. Puri RK, Leland P, Kreitman RJ, Pastan I: Human neurological cancer cells express interleukin-4 (IL-4) receptors which are targets for the toxic effects of IL-4-Pseudomonas exotoxin chimeric protein. Int J Cancer 58:574-581, 1994.
25. Recht LD, Griffin TW, Raso V, Salimi AR: Potent cytotoxicity of an antihuman transferrin receptor-ricin A chain immunotoxin on human glioma cells in vitro. Cancer Res 50:6696-6700, 1990.
26. Recht L, Torres CO, Smith TW, Raso V, Griffin TW: Transferrin receptor in normal and neoplastic brain tissue: Implications for brain tumor immunotherapy. J Neurosurg 72:941-945, 1990.
27. Siegall CB: Targeted toxins as anticancer agents. Cancer 74:1006-1012, 1994.
28. Sung C, Dedrick RL, Hall WA, Johnson PA, Youle RJ: The spatial distribution of immunotoxins in solid tumors: Assessment by quantitative autoradiography. Cancer Res 53:2092-2099, 1993.
29. Wen DY, Hall WA, Conrad J, Godal A, Florenes VA, Fodstad Ø: In vitro and in vivo variation in transferrin receptor expression on a human medulloblastoma cell line. Neurosurgery 36:1158-1164, 1995.
30. Wen DY, Hall WA, Fodstad Ø: Rapid detection of transferrin receptor expression on glioma cell lines by using magnetic microspheres. Neurosurgery 33:878-881, 1993.
31. Wrobel CJ, Wright DC, Dedrick RL, Youle RJ: Diphtheria toxin effects on brain-tumor xenografts: Implications for protein-based brain-tumor chemotherapy. J Neurosurg 72:946-950, 1988.
32. Zovickian J, Youle RJ: Efficacy of intrathecal immunotoxin therapy in an animal model of leptomeningeal neoplasia. J Neurosurg 68:767-774, 1988.
33. Zovickian J, Johnson VG, Youle RJ: Potent and specific killing of human malignant brain tumor cells by an anti-transferrin receptor antibody-ricin immunotoxin. J Neurosurg 66:850-861, 1987.